FDA Guidance Recap Podcast
Guidance Recap Podcast | Bioavailability Studies Submitted in NDAs or INDs – General Considerations
Listen now
Description
Guidance Recap Podcast: Bioavailability Studies Submitted in NDAs or INDs – General Considerations
More Episodes
See all »
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development
Published 10/16/24
Guidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Published 09/18/24
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Published 07/24/24
All episodes
 
Links
fda.gov
RSS feed
Listen on Apple Podcasts
Twitter
Facebook
Instagram
Patreon
 
Genres
Government
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
Podcasts
Podcast Reviews
Podcast Charts
Accounts
Log in
Terms
Privacy Policy
Help
FAQ
[email protected]
Service status
© 2024 Chartable Holding, LLC
Certified by the IAB Tech Lab SOC2 Type II Certified